RE: Whare are the chances?25 Jul 2021 15:28
thought provoking indeed MAF'' it look like they are all confused
about what the virus can or can't do, but won't say, and how it's laughing
in the face of any vaccine but they won't say'' what we have here is a very confuse
science community with no clue'' and all contradicting each other...
and they wonder why half the general public is worried about getting a jab with only
1 year of research... and although it help to keep people out of the hospital
and save lives, we don't know how long for, thought provoking indeed'''
''abstract'' can anyone make sense of it?
So far, no proof exists of mutations that would make the virus more pathogenic or that might help the virus evade immunity. But a recent preprint by a team at the Swedish Medical Center in Seattle suggests one may exist. The team describes a person who was infected in March and reinfected 4 months later. The second virus had a mutation common in Europe that causes a slight change in the virus’ spike protein, which helps it break into human cells. Although symptoms were milder the second time, neutralization experiments showed antibodies elicited by the first virus did not work well against the second, the authors note, “which could have important implications for the success of vaccine programs.”
And some scientists worry about another scenario that could make the second episode worse: enhanced disease, in which a misfiring immune response to the first infection exacerbates the second one. In dengue fever, for example, antibodies to an initial infection can actually help dengue viruses of another serotype enter cells, leading to a more severe and sometimes fatal second infection. In some other diseases, the first infection triggers ineffective, nonneutralizing antibodies and T cells, hampering a more effective response the second time around.
THE WORLD NEED AN ALTERNATIVE IN 1801, AS IT'S PERHAPS ALL ABOUT THE STORM..
stopping an over active immune system could be the key''
back to SAR'' next week could be interesting
308
Sign In
Follow the stocks
